Journal News

Glutathione pathway implicated in rare disease

Pearce Hyatt
By Pearce Hyatt
March 19, 2026

Methylmalonic aciduria, or MMA, is a rare inherited metabolic disorder in which the body cannot break down certain amino acids and lipids. This leads to a buildup of methylmalonic acid and other metabolites in tissues and body fluids, and is associated with conditions like oxidative stress and mitochondrial dysfunction. However, MMA’s complex underlying mechanisms of action remain unresolved.

Integrative multiomics has emerged as a tool to help better understand the underlying pathogenesis of the disease. Jianbo Fu, Sandra Goetze and a team of researchers in Switzerland provide an analysis framework to integrate complex data types. They published their framework in Molecular & Cellular Proteomics.

The team obtained DNA, RNA, protein and metabolite information from MMA patients. Using their multiomics framework, which links genetic variants to protein levels, they identified glutathione metabolism as a central pathway in MMA pathogenesis.

This study illustrates how multiomics approaches can reveal underlying mechanisms in complex diseases, highlighting potential targets for future therapeutic strategies.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Pearce Hyatt
Pearce Hyatt

Pearce Hyatt is an incoming medical student at Wake Forest School of Medicine. He spent two years working at the Laboratory of Viral Diseases at the National Institutes of Health and is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Blood glycome possibly predicts lifespan
Journal News

Blood glycome possibly predicts lifespan

May 21, 2026

Researchers at the University of Santiago de Compostela show that total serum N-glycome can predict mortality independent of traditional risk factors.

Building a better model for drug delivery across the blood–brain barrier
Journal News

Building a better model for drug delivery across the blood–brain barrier

May 19, 2026

Industry and academic scientists collaborated to develop a rat with humanized iron-transport receptors, enabling research into iron homeostasis and drugs that cross the brain’s barrier.

Fat synthesis enzyme crucial for milk fat and newborn growth
Journal News

Fat synthesis enzyme crucial for milk fat and newborn growth

May 14, 2026

Researchers found that a deficiency of the fatty acid synthesis enzyme stearoyl-CoA desaturase-1 reduced mammary gland function during lactation and caused low birth weight in newborns that were fed milk from enzyme-deficient glands.

Flipping lipids and slime molds
Interview

Flipping lipids and slime molds

May 12, 2026

A dull first job nearly pushed JBC associate editor Todd Graham out of science. Then a slime mold project changed his path. Now, he studies membrane biology and reflects on discovery, persistence and mentoring through uncertainty.

How smelling death alters worm behavior
News

How smelling death alters worm behavior

May 7, 2026

Researchers have found that the roundworm C. elegans can smell death, and it changes how the worms behave, reproduce and age.

A chance encounter with the lab
Profile

A chance encounter with the lab

May 5, 2026

Payton Stevens never planned to become a pancreatic cancer researcher. A temporary job set him on a path from rural Kentucky to leading research on Wnt signaling and metastasis, where he now pairs discovery with mentorship and science advocacy.